Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation

Biochemical and Biophysical Research Communications

Volumn 397, Issue 4, 2010, Pages 644-649

  Shin, Suk Chul ^a   Lee, Kyung Mi ^b   Kang, Yu Mi ^a   Kim, Kwanghee ^b   Kim, Cha Soon ^a   Yang, Kwang Hee ^a   Jin, Young Woo ^a   Kim, Chong Soon ^c   Kim, Hee Sun ^a  

^a Korea Hydro & Nuclear Power Co   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Adaptive response; Cytokine; Hormesis; Low dose radiation; Lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 3; INTERLEUKIN 4; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; THROMBOPOIETIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; ERYTHROCYTE COUNT; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; IONIZING RADIATION; LEUKOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; TH1 CELL; TH2 CELL; THROMBOCYTE COUNT;

ANIMALS; BLOOD CELLS; BODY WEIGHT; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; IMMUNITY; LYMPHOCYTES; MICE; MICE, INBRED C57BL;

ANIMALIA; MUS;

EID: 77954383141     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.05.121     Document Type: Article

References (33)

1. Huang L., Snyder A.R., Morgan W.F. Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene 2003, 22:5848-5854.
2. Luckey T.D. Physiological benefits from low levels of ionizing radiation. Health Phys. 1982, 43:771-789.
3. Iyer R., Lehnert B.E. Low dose, low-LET ionizing radiation-induced radioadaptation and associated early responses in unirradiated cells. Mutat. Res. 2002, 503:1-9.
4. Miura Y., Abe K., Urano S., Furuse T., Noda Y., Tatsumi K., Suzuki S. Adaptive response and the influence of ageing: effects of low-dose irradiation on cell growth of cultured glial cells. Int. J. Radiat. Biol. 2002, 78:913-921.
5. Liu S.Z., Liu W.H., Sun J.B. Radiation hormesis: its expression in the immune system. Health Phys. 1987, 52:579-583.
6. Lacoste-Collin L., Jozan S., Cances-Lauwers V., Pipy B., Gasset G., Caratero C., Courtade-Saidi M. Effect of continuous irradiation with a very low dose of gamma rays on life span and the immune system in SJL mice prone to B-cell lymphoma. Radiat. Res. 2007, 168:725-732.
7. Ina Y., Sakai K. Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains: analysis of immune cell populations and surface molecules. Int. J. Radiat. Biol. 2005, 81:721-729.
8. Ishii K., Hosoi Y., Yamada S., Ono T., Sakamoto K. Decreased incidence of thymic lymphoma in AKR mice as a result of chronic, fractionated low-dose total-body X irradiation. Radiat. Res. 1996, 146:582-585.
9. Ina Y., Tanooka H., Yamada T., Sakai K. Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice. Radiat. Res. 2005, 163:153-158.
10. Ina Y., Sakai K. Prolongation of life span associated with immunological modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice. Radiat. Res. 2004, 161:168-173.
11. Hashimoto S., Shirato H., Hosokawa M., Nishioka T., Kuramitsu Y., Matushita K., Kobayashi M., Miyasaka K. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat. Res. 1999, 151:717-724.
12. Yu H.S., Song A.Q., Lu Y.D., Qiu W.S., Shen F.Z. Effects of low-dose radiation on tumor growth, erythrocyte immune function and SOD activity in tumor-bearing mice. Chin. Med. J. (Engl.) 2004, 117:1036-1039.
13. UNSCEAR, Volume I and II, United Nations Sales Publication E.00.IX.3 and E.00.IX.4 United Nations, New York, 2000.
14. Hoshi Y., Nomura T., Oda T., Iwasaki T., Fujita K., Ishikawa T., Kato A., Ikegami T., Sakai K., Tanooka H., Yamada T. Application of a newly developed photoluminescence glass dosimeter for measuring the absorbed dose in individual mice exposed to low-dose rate 137Cs gamma-rays. J. Radiat. Res. (Tokyo) 2000, 41:129-137.
15. Jung S., Park Y.K., Lee H., Shin J.H., Lee G.R., Park S.H. TGF-beta-treated antigen presenting cells suppress collagen-induced arthritis through the promotion of Th2 responses. Exp. Mol. Med. 2010, 42:187-194.
16. Bianchi L.M., Daruwalla Z., Roth T.M., Attia N.P., Lukacs N.W., Richards A.L., White I.O., Allen S.J., Barald K.F. Immortalized mouse inner ear cell lines demonstrate a role for chemokines in promoting the growth of developing statoacoustic ganglion neurons. J. Assoc. Res. Otolaryngol. 2005, 6:355-367.
17. Metcalf D. Hematopoietic cytokines. Blood 2008, 111:485-491.
18. Takahashi M., Galligan C., Tessarollo L., Yoshimura T. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J. Immunol. 2009, 183:3463-3471.
19. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., Luster A.D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 1997, 185:99-109.
20. Charmoy M., Brunner-Agten S., Aebischer D., Auderset F., Launois P., Milon G., Proudfoot A.E., Tacchini-Cottier F. Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS Pathog. 2010, 6:e1000755.
21. Kaushansky K. Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 2006, 354:2034-2045.
22. Wang Y., Nakayama M., Pitulescu M.E., Schmidt T.S., Bochenek M.L., Sakakibara A., Adams S., Davy A., Deutsch U., Luthi U., Barberis A., Benjamin L.E., Makinen T., Nobes C.D., Adams R.H. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010, 465:483-486.
23. Brennan A.M., Mantzoros C.S. Drug insight: the role of leptin in human physiology and pathophysiology - emerging clinical applications. Nat. Clin. Pract. Endocrinol. Metab. 2006, 2:318-327.
24. Trinchieri G., Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 1995, 146:423-431.
25. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C.-y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., Gately M.K. IL-12-deficient mice are defective in IFN[gamma] production and type 1 cytokine responses. Immunity 1996, 4:471-481.
26. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
27. Blease K., Jakubzick C., Westwick J., Lukacs N., Kunkel S.L., Hogaboam C.M. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J. Immunol. 2001, 166:5219-5224.
28. Aggarwal S., Gurney A.L. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 2002, 71:1-8.
29. Nakatsukasa H., Tsukimoto M., Ohshima Y., Tago F., Masada A., Kojima S. Suppressing effect of low-dose gamma-ray irradiation on collagen-induced arthritis. J. Radiat. Res. (Tokyo) 2008, 49:381-389.
30. Kojima S. Induction of glutathione and activation of immune functions by low-dose, whole-body irradiation with gamma-rays. Yakugaku Zasshi 2006, 126:849-857.
31. Suzuki K., Kodama S., Watanabe M. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells. Cancer Res. 2001, 61:5396-5401.
32. Suzuki K., Kodama S., Watanabe M. Low-dose radiation effects and intracellular signaling pathways. Yakugaku Zasshi 2006, 126:859-867.
33. Santo L., Vallet S., Hideshima T., Cirstea D., Ikeda H., Pozzi S., Patel K., Okawa Y., Gorgun G., Perrone G., Calabrese E., Yule M., Squires M., Ladetto M., Boccadoro M., Richardson P.G., Munshi N.C., Anderson K.C., Raje N. AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. Oncogene 2010, 29:2325-2336.